Improving the clinical risk score: An analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Colorectal Neoplasms
  • Drug Therapy
  • Hepatectomy
  • Liver Neoplasms

abstract

  • In patients with hepatic CRCLM treated with resection and modern chemotherapy, increased expression of TS improves outcome stratification and appears to be a useful biomarker.

publication date

  • February 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.surg.2011.07.020

PubMed ID

  • 21982065

Additional Document Info

start page

  • 162

end page

  • 70

volume

  • 151

number

  • 2